JamieLeeFraserMDPhD

Medical Genetics • Washington, DC

Clinical Genetics, Medical Biochemical Genetics

Medical Biochemical Geneticist Rare Disease Institute Children’s National Health System

Join to view full profile

Dr. Fraser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fraser's full profile

Already have an account?

Office
7125 13th Pl NW
Washington, DC 20012
Phone+1 202-545-2500

Summary

Dr. Jamie Fraser is a medical geneticist in Washington, DC and is affiliated with Children's National Hospital. She received her medical degree from Medical University of South Carolina College of Medicine and has been in practice 7 years. She specializes in clinical genetics and medical biochemical genetics and is experienced in leukodystrophy, inborn errors of metabolism, neurogenetics, and metabolic brain injury.

Education & Training

National Institutes of Health Clinical CenterFellowship, Medical Biochemical Genetics, 2015 - 2016
National Institutes of Health Clinical CenterResidency, Medical Genetics and Genomics, 2010 - 2015
Children's National HospitalResidency, Pediatrics, 2010 - 2013
Medical University of South CarolinaClass of 2010

Certifications & Licensure

MD State Medical License 2016 - 2026
VA State Medical License 2020 - 2026
DC State Medical License 2012 - 2024
American Board of Medical Genetics and Genomics Medical Biochemical Genetics
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Publications & Presentations

PubMed

22 citations
RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.
Marisa I. Mendes, Lydia Green, Enrico Bertini, Davide Tonduti, Chiara Aiello
Annals of Clinical and Translational Neurology. 2020-01-01
447 citations
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis
Xinyang Hu, Shan Ping Yu, Jamie L. Fraser, Zhongyang Lu, Molly E. Ogle
The Journal of Thoracic and Cardiovascular Surgery. 2008-04-01
59 citations
De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism
Maria J. Guillen Sacoto, Iva A. Tchasovnikarova, Erin Torti, Cara Forster, E. Hallie Andrew
American Journal of Human Genetics. 2020-08-06